Michael Sapienza, Chief Executive Officer of the Colorectal Cancer Alliance, shared a post on LinkedIn:
“Each year, American Society of Clinical Oncology (ASCO) offers a glimpse of where cancer research stands today and where patient care is headed next. It gathers the brightest minds, and the Colorectal Cancer Alliance was there to ensure we are keeping pace with and fueling progress.
Join us at 4 pm ET tomorrow to hear our experts break down advances for colorectal cancer patients, plus share what we accomplished on the ground in Chicago, including the launch of KLEOS, our own clinical trial platform to accelerate cures.
This year’s conversations reinforced something that has become increasingly clear: progress is no longer driven by individual breakthroughs alone. It is driven by collaboration, smarter clinical research, and a shared commitment to moving discoveries to patients faster.
Scientific progress is measured in data, but its true impact is measured in lives changed. Every improvement in how we design studies, share knowledge, connect patients and work together brings us one step closer to better treatments and better outcomes for patients.
Thank you to everyone who helped make this year’s ASCO Annual Meeting such a meaningful opportunity to learn, collaborate, and continue pushing the field forward.
Make sure to register for the recap and learn more.”
Other articles about Colorectal Cancer on OncoDaily.